-
-
Most cases of thrombocytopenia seen are expected. Patients are known to have hematological disease or are receiving chemotherapy. At times, however, the physician is confronted with an unexpected laboratory finding in an asymptomatic patient, or with a patient who is bleeding. The challenge, as usual, is to determine the need for acute treatment and the appropriate disposition.
-
Stop smoking drug Chantix rates stronger warning from FDA; Type 2 diabetes surgery on the way?; Vytorin study inconclusive; Influenza A virus found resistant to Tamiflu; FDA actions.
-
Duct tape is no more effective than moleskin for the treatment of common warts. Occlusion therapy with both for 7 days will give resolution in just over 20% of patients.
-
Increasing use of CT scans has led to an increase of radiation exposure to its recipients, potentially causing up to 2% of new cancers, especially in children.
-
The FDA has approved extended release niacin plus simvastatin as a combination product.
-
Does Published Evidence Reflect the Whole Story?, Vitamin E levels and Physical Decline with Aging, Effort, Efficacy, and Effectiveness
-
The onset of dementia heralds death in about 41/2 years.
-
The atrial fibrillation clopidogrel trial with Irbesartan for Prevention of Vascular Events (ACTIVE W) is a noninferiority trial comparing anticoagulation with warfarin to therapy with aspirin plus clopidogrel for stroke prevention in patients with atrial fibrillation.
-
12-lead ECG and lead II rhythm strip obtained from a 90-year-old woman with acute dyspnea and diaphoresis.
